Moreover, the tumor-derived soluble MICA induced endocytosis and degradation of the cognate activatory receptor NKG2-D on tumor-infiltrating lymphocytes, impairing their activation [29], [39]. The gene discussed is KLRK1; the disease is neoplasm.